MedPath

Facilitating Routine HIV Testing Among MSM by a Subscription-based Self-test Distribution Model

Not Applicable
Not yet recruiting
Conditions
Hiv
Interventions
Behavioral: Text reminder
Behavioral: HIV self-test
Registration Number
NCT06189729
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

The goal of this stepped wedge trial is to assess if a subscription-based HIV self-test distribution model could facilitate routine HIV testing in the men who have sex with men community. The main questions it aims to answer are the effectiveness of the model in enhancing routine HIV testing and its acceptability in the community. The 1-year observation period would be divided into control and intervention period. Participants will be reminded to get HIV tested via instant messaging apps or short message service during the control period. During the intervention period, the researchers will deliver an HIV self-test to the participants. Researchers will compare the testing rate between the two periods to see if the intervention can facilitate HIV testing.

Detailed Description

Participants would be assigned randomly to a sequence group and crossed over from the control to intervention. In this study, the 1-year observation period is divided into four three-month intervals. All sequences would start with a control period. The three sequences would cross over to the intervention at Month 3, 6, and 9, respectively. All participants would therefore eventually receive intervention. The investigators adopt an mHealth approach for both control and intervention. Based on the results of a previous study that text messages through short message service (SMS) and instant messing (IM) apps are acceptable and feasible in promoting HIV self-management, participants during the control period would receive trimonthly text reminders through their designated IM app or SMS. The message would invite them to get HIV tested with free VCT service provider information. After 14 days, a follow-up message with the link to an online survey would be sent to enquire whether the participants had been tested or not. Participants during the intervention period would receive a trimonthly text messages asking them to choose a pickup point run by the delivery company to collect the free HIVST. Upon receiving the delivery instruction, the HIVST with bilingual (Chinese and English) instructions would be delivered to the designated location. Participants would be asked to perform the self-test and return the photographed result within 14 days. Similarly, after 14 days, a follow-up message with the link to an online survey would be sent to ask them to upload the photo of the test result. The uploaded images would be verified by the research team who are experienced in reading HIVST results both online and offline. Follow-up confirmation testing and medical service referral would be offered if the result was indeterminate or suspected to be positive. If the results were not returned after 14 days, an exit survey would be sent to the participants through IM apps or SMS.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Male
Target Recruitment
240
Inclusion Criteria
  • be aged 18 years or above
  • be biologically male
  • have ever had sex with another men
  • have more than 1 male sex partners in the past 6 months
  • normally reside in Hong Kong
  • be able to communicate in written and spoken Chinese or English
Read More
Exclusion Criteria
  • previously HIV diagnosis
  • unable or unwilling to give informed consent, to complete the questionnaires, to receive text messages as scheduled and when necessary, and to provide the mobile phone number to receive text messages for reminders and delivery notices
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Cluster 1Text reminderParticipants will receive text reminders at Month 0 only. They will receive an HIV self-test at Months 3, 6, 9 and 12, upon submission of the self-test result.
Cluster 3Text reminderParticipants will receive text reminders at Months 0, 3 and 6. They will receive an HIV self-test at Months 9 and 12, upon submission of the self-test result.
Cluster 3HIV self-testParticipants will receive text reminders at Months 0, 3 and 6. They will receive an HIV self-test at Months 9 and 12, upon submission of the self-test result.
Cluster 1HIV self-testParticipants will receive text reminders at Month 0 only. They will receive an HIV self-test at Months 3, 6, 9 and 12, upon submission of the self-test result.
Cluster 2HIV self-testParticipants will receive text reminders at Months 0 and 3. They will receive an HIV self-test at Months 6, 9 and 12, upon submission of the self-test result.
Cluster 2Text reminderParticipants will receive text reminders at Months 0 and 3. They will receive an HIV self-test at Months 6, 9 and 12, upon submission of the self-test result.
Primary Outcome Measures
NameTimeMethod
Proportion of HIV tests performed with result returnedMonth 3 to Month 12

Number of HIV self-test results returned divided by the total number of HIV self-tests delivered

Retention rateMonth 12

Proportion of participants completed the questionnaire at Month 12

Secondary Outcome Measures
NameTimeMethod
HIV incidenceMonth 3 to Month 12

Dividing the number of laboratory confirmed HIV-positive results by the total number of person-years

Linkage to care rateMonth 3 to Month 12

The proportion of tests requiring further confirmation and medical service referral.

Single ease questionMonth 3 to Month 12

In a scale of 1-7, how easy or difficult was the task was?

Net promoter scoreMonth 3 to Month 12

In a scale of 0-10, how likely would the participant recommend this model to their peers?

System usability scaleMonth 3 to Month 12

There are ten 5-point Likert scale questions. The scores would be summed and multiply by a factor of 2.5 according to the formula to come up with the score between 0 to 100.

Trial Locations

Locations (1)

Stanley Ho Centre for Emerging Infectious Diseases

🇭🇰

Sha Tin, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath